Compare stocks

Ypsomed Holding AG is a Swiss company specializing in the development and manufacturing of injection and infusion systems for self-medication, primarily serving the pharmaceuticals and biotechnology industries. Its key products include insulin pens, autoinjectors, infusion sets, and digital health solutions, catering to therapy areas such as diabetes management. Founded in 1984, the company is headquartered in Burgdorf, Switzerland, and operates globally with subsidiaries and distributors across Europe, North America, and Asia-Pacific regions. Ypsomed leverages its expertise in precision injection technology and its strategic partnerships with leading drug manufacturers to maintain its competitive position in the medical technology sector.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.